Form 4 for MIRA MIRA PHARMACEUTICALS, INC.
Accepted 2024-11-27 00:00:00 ET · period of report 2024-11-19 · accession 0001493152-24-047998 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-11-27 | 2024-11-19+ | MIRA | Aminov Erez | CEO, Dir | S - Sale | $1.34 | -100.0K | 1.11M | -8% | -$133.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-20 | S | D | 44,590 | $1.27 | 1,061,200 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. |
| 2 | Common | Common Stock | 2024-11-19 | S | D | 55,410 | $1.39 | 1,105,790 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. |